Personal Cfo Solutions, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Personal Cfo Solutions, LLC

  • $704 Million
  • Q3 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 561 shares of REGN stock, worth $417,720. This represents 0.08% of its overall portfolio holdings.

Number of Shares
561
Previous 528 6.25%
Holding current value
$417,720
Previous $554,000 6.32%
% of portfolio
0.08%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $33,794 - $39,658
33 Added 6.25%
561 $589,000
Q2 2024

Aug 09, 2024
BUY
$883.2 - $1071.19 $15,897 - $19,281
18 Added 3.53%
528 $554,000
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $14,443 - $15,893
-16 Reduced 3.04%
510 $490,000
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $49,611 - $56,428
-64 Reduced 10.85%
526 $461,000
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $1,384 - $1,688
-2 Reduced 0.34%
590 $485,000
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $11,200 - $13,285
-16 Reduced 2.63%
592 $425,000
Q1 2023

May 09, 2023
BUY
$680.49 - $826.97 $19,053 - $23,155
28 Added 4.83%
608 $499,000
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $103,059 - $111,892
-146 Reduced 20.11%
580 $418,000
Q3 2022

Nov 01, 2022
SELL
$573.97 - $724.32 $17,793 - $22,453
-31 Reduced 4.1%
726 $500,000
Q2 2022

Aug 05, 2022
BUY
$548.35 - $738.84 $2,193 - $2,955
4 Added 0.53%
757 $447,000
Q1 2022

May 02, 2022
SELL
$595.12 - $698.43 $210,077 - $246,545
-353 Reduced 31.92%
753 $526,000
Q4 2021

Feb 11, 2022
BUY
$543.48 - $670.97 $249,457 - $307,975
459 Added 70.94%
1,106 $698,000
Q3 2021

Nov 18, 2021
BUY
$574.03 - $680.96 $371,397 - $440,581
647 New
647 $392,000
Q1 2021

Apr 21, 2021
SELL
$446.73 - $548.2 $759,887 - $932,488
-1,701 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$478.3 - $607.98 $40,655 - $51,678
85 Added 5.26%
1,701 $821,000
Q3 2020

Nov 02, 2020
SELL
$544.75 - $658.21 $54,475 - $65,821
-100 Reduced 5.83%
1,616 $1,000
Q2 2020

Aug 03, 2020
BUY
$493.32 - $643.92 $5,426 - $7,083
11 Added 0.65%
1,716 $1.07 Million
Q1 2020

Apr 30, 2020
BUY
$336.18 - $494.43 $41,013 - $60,320
122 Added 7.71%
1,705 $833,000
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $40,297 - $55,346
-147 Reduced 8.5%
1,583 $593,000
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $473,085 - $550,814
1,730 New
1,730 $480,000

Others Institutions Holding REGN

# of Institutions
1,530
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email